Cargando…

One-Year Effects of Omega-3 Treatment on Fatty Acids, Oxylipins, and Related Bioactive Lipids and Their Associations with Clinical Lipid and Inflammatory Biomarkers: Findings from a Substudy of the Vitamin D and Omega-3 Trial (VITAL)

Omega-3 (n-3) treatment may lower cardiovascular risk, yet its effects on the circulating lipidome and relation to cardiovascular risk biomarkers are unclear. We hypothesized that n-3 treatment is associated with favorable changes in downstream fatty acids (FAs), oxylipins, bioactive lipids, clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Demler, Olga V., Liu, Yanyan, Luttmann-Gibson, Heike, Watrous, Jeramie D., Lagerborg, Kim A., Dashti, Hesam, Giulianini, Franco, Heath, Mallory, Camargo, Carlos A., Harris, William S., Wohlgemuth, Jay G., Andres, Allen M., Tivari, Saumya, Long, Tao, Najhawan, Mahan, Dao, Khoi, Prentice, James G., Larsen, Julia A., Okereke, Olivia I., Costenbader, Karen H., Buring, Julie E., Manson, JoAnn E., Cheng, Susan, Jain, Mohit, Mora, Samia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693376/
https://www.ncbi.nlm.nih.gov/pubmed/33120862
http://dx.doi.org/10.3390/metabo10110431
_version_ 1783614729797763072
author Demler, Olga V.
Liu, Yanyan
Luttmann-Gibson, Heike
Watrous, Jeramie D.
Lagerborg, Kim A.
Dashti, Hesam
Giulianini, Franco
Heath, Mallory
Camargo, Carlos A.
Harris, William S.
Wohlgemuth, Jay G.
Andres, Allen M.
Tivari, Saumya
Long, Tao
Najhawan, Mahan
Dao, Khoi
Prentice, James G.
Larsen, Julia A.
Okereke, Olivia I.
Costenbader, Karen H.
Buring, Julie E.
Manson, JoAnn E.
Cheng, Susan
Jain, Mohit
Mora, Samia
author_facet Demler, Olga V.
Liu, Yanyan
Luttmann-Gibson, Heike
Watrous, Jeramie D.
Lagerborg, Kim A.
Dashti, Hesam
Giulianini, Franco
Heath, Mallory
Camargo, Carlos A.
Harris, William S.
Wohlgemuth, Jay G.
Andres, Allen M.
Tivari, Saumya
Long, Tao
Najhawan, Mahan
Dao, Khoi
Prentice, James G.
Larsen, Julia A.
Okereke, Olivia I.
Costenbader, Karen H.
Buring, Julie E.
Manson, JoAnn E.
Cheng, Susan
Jain, Mohit
Mora, Samia
author_sort Demler, Olga V.
collection PubMed
description Omega-3 (n-3) treatment may lower cardiovascular risk, yet its effects on the circulating lipidome and relation to cardiovascular risk biomarkers are unclear. We hypothesized that n-3 treatment is associated with favorable changes in downstream fatty acids (FAs), oxylipins, bioactive lipids, clinical lipid and inflammatory biomarkers. We examined these VITAL200, a nested substudy of 200 subjects balanced on demographics and treatment and randomly selected from the Vitamin D and Omega-3 Trial (VITAL). VITAL is a randomized double-blind trial of 840 mg/d eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) vs. placebo among 25,871 individuals. Small polar bioactive lipid features, oxylipins and FAs from plasma and red blood cells were measured using three independent assaying techniques at baseline and one year. The Women’s Health Study (WHS) was used for replication with dietary n-3 intake. Randomized n-3 treatment led to changes in 143 FAs, oxylipins and bioactive lipids (False Discovery Rate (FDR) < 0.05 in VITAL200, validated (p-values < 0.05)) in WHS with increases in 95 including EPA, DHA, n-3 docosapentaenoic acid (DPA-n3), and decreases in 48 including DPA-n6, dihomo gamma linolenic (DGLA), adrenic and arachidonic acids. N-3 related changes in the bioactive lipidome were heterogeneously associated with changes in clinical lipid and inflammatory biomarkers. N-3 treatment significantly modulates the bioactive lipidome, which may contribute to its clinical benefits.
format Online
Article
Text
id pubmed-7693376
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76933762020-11-28 One-Year Effects of Omega-3 Treatment on Fatty Acids, Oxylipins, and Related Bioactive Lipids and Their Associations with Clinical Lipid and Inflammatory Biomarkers: Findings from a Substudy of the Vitamin D and Omega-3 Trial (VITAL) Demler, Olga V. Liu, Yanyan Luttmann-Gibson, Heike Watrous, Jeramie D. Lagerborg, Kim A. Dashti, Hesam Giulianini, Franco Heath, Mallory Camargo, Carlos A. Harris, William S. Wohlgemuth, Jay G. Andres, Allen M. Tivari, Saumya Long, Tao Najhawan, Mahan Dao, Khoi Prentice, James G. Larsen, Julia A. Okereke, Olivia I. Costenbader, Karen H. Buring, Julie E. Manson, JoAnn E. Cheng, Susan Jain, Mohit Mora, Samia Metabolites Article Omega-3 (n-3) treatment may lower cardiovascular risk, yet its effects on the circulating lipidome and relation to cardiovascular risk biomarkers are unclear. We hypothesized that n-3 treatment is associated with favorable changes in downstream fatty acids (FAs), oxylipins, bioactive lipids, clinical lipid and inflammatory biomarkers. We examined these VITAL200, a nested substudy of 200 subjects balanced on demographics and treatment and randomly selected from the Vitamin D and Omega-3 Trial (VITAL). VITAL is a randomized double-blind trial of 840 mg/d eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) vs. placebo among 25,871 individuals. Small polar bioactive lipid features, oxylipins and FAs from plasma and red blood cells were measured using three independent assaying techniques at baseline and one year. The Women’s Health Study (WHS) was used for replication with dietary n-3 intake. Randomized n-3 treatment led to changes in 143 FAs, oxylipins and bioactive lipids (False Discovery Rate (FDR) < 0.05 in VITAL200, validated (p-values < 0.05)) in WHS with increases in 95 including EPA, DHA, n-3 docosapentaenoic acid (DPA-n3), and decreases in 48 including DPA-n6, dihomo gamma linolenic (DGLA), adrenic and arachidonic acids. N-3 related changes in the bioactive lipidome were heterogeneously associated with changes in clinical lipid and inflammatory biomarkers. N-3 treatment significantly modulates the bioactive lipidome, which may contribute to its clinical benefits. MDPI 2020-10-27 /pmc/articles/PMC7693376/ /pubmed/33120862 http://dx.doi.org/10.3390/metabo10110431 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Demler, Olga V.
Liu, Yanyan
Luttmann-Gibson, Heike
Watrous, Jeramie D.
Lagerborg, Kim A.
Dashti, Hesam
Giulianini, Franco
Heath, Mallory
Camargo, Carlos A.
Harris, William S.
Wohlgemuth, Jay G.
Andres, Allen M.
Tivari, Saumya
Long, Tao
Najhawan, Mahan
Dao, Khoi
Prentice, James G.
Larsen, Julia A.
Okereke, Olivia I.
Costenbader, Karen H.
Buring, Julie E.
Manson, JoAnn E.
Cheng, Susan
Jain, Mohit
Mora, Samia
One-Year Effects of Omega-3 Treatment on Fatty Acids, Oxylipins, and Related Bioactive Lipids and Their Associations with Clinical Lipid and Inflammatory Biomarkers: Findings from a Substudy of the Vitamin D and Omega-3 Trial (VITAL)
title One-Year Effects of Omega-3 Treatment on Fatty Acids, Oxylipins, and Related Bioactive Lipids and Their Associations with Clinical Lipid and Inflammatory Biomarkers: Findings from a Substudy of the Vitamin D and Omega-3 Trial (VITAL)
title_full One-Year Effects of Omega-3 Treatment on Fatty Acids, Oxylipins, and Related Bioactive Lipids and Their Associations with Clinical Lipid and Inflammatory Biomarkers: Findings from a Substudy of the Vitamin D and Omega-3 Trial (VITAL)
title_fullStr One-Year Effects of Omega-3 Treatment on Fatty Acids, Oxylipins, and Related Bioactive Lipids and Their Associations with Clinical Lipid and Inflammatory Biomarkers: Findings from a Substudy of the Vitamin D and Omega-3 Trial (VITAL)
title_full_unstemmed One-Year Effects of Omega-3 Treatment on Fatty Acids, Oxylipins, and Related Bioactive Lipids and Their Associations with Clinical Lipid and Inflammatory Biomarkers: Findings from a Substudy of the Vitamin D and Omega-3 Trial (VITAL)
title_short One-Year Effects of Omega-3 Treatment on Fatty Acids, Oxylipins, and Related Bioactive Lipids and Their Associations with Clinical Lipid and Inflammatory Biomarkers: Findings from a Substudy of the Vitamin D and Omega-3 Trial (VITAL)
title_sort one-year effects of omega-3 treatment on fatty acids, oxylipins, and related bioactive lipids and their associations with clinical lipid and inflammatory biomarkers: findings from a substudy of the vitamin d and omega-3 trial (vital)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693376/
https://www.ncbi.nlm.nih.gov/pubmed/33120862
http://dx.doi.org/10.3390/metabo10110431
work_keys_str_mv AT demlerolgav oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT liuyanyan oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT luttmanngibsonheike oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT watrousjeramied oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT lagerborgkima oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT dashtihesam oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT giulianinifranco oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT heathmallory oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT camargocarlosa oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT harriswilliams oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT wohlgemuthjayg oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT andresallenm oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT tivarisaumya oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT longtao oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT najhawanmahan oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT daokhoi oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT prenticejamesg oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT larsenjuliaa oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT okerekeoliviai oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT costenbaderkarenh oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT buringjuliee oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT mansonjoanne oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT chengsusan oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT jainmohit oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital
AT morasamia oneyeareffectsofomega3treatmentonfattyacidsoxylipinsandrelatedbioactivelipidsandtheirassociationswithclinicallipidandinflammatorybiomarkersfindingsfromasubstudyofthevitamindandomega3trialvital